NO329977B1 - Fremgangsmate for pavisning av minst ett nukleinsyremal og sett for pavisning av minst ett nukleinsyremal i en prove - Google Patents

Fremgangsmate for pavisning av minst ett nukleinsyremal og sett for pavisning av minst ett nukleinsyremal i en prove Download PDF

Info

Publication number: NO329977B1
Authority: NO; Norway
Prior art keywords: target; nucleic acid; specific; anchors; approx
Prior art date: 1997-12-19

Application number

NO20003115A

Other languages

English (en)

Norwegian (no)

Other versions

NO20003115L (no

NO20003115D0 (no

Inventor

Stephen Felder

Richard M Kris

Original Assignee

Stephen Felder

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-19

Filing date

2000-06-16

Publication date

2011-01-31

2000-06-16 Application filed by Stephen Felder filed Critical Stephen Felder

2000-06-16 Publication of NO20003115D0 publication Critical patent/NO20003115D0/no

2000-08-21 Publication of NO20003115L publication Critical patent/NO20003115L/no

2011-01-31 Publication of NO329977B1 publication Critical patent/NO329977B1/no

Links

238000000034 method Methods 0.000 title claims abstract description 127
150000007523 nucleic acids Chemical class 0.000 title claims description 117
102000039446 nucleic acids Human genes 0.000 title claims description 114
108020004707 nucleic acids Proteins 0.000 title claims description 114
239000000523 sample Substances 0.000 claims abstract description 262
230000001588 bifunctional effect Effects 0.000 claims abstract description 26
230000000694 effects Effects 0.000 claims abstract description 14
108091034117 Oligonucleotide Proteins 0.000 claims description 199
239000012634 fragment Substances 0.000 claims description 130
230000004224 protection Effects 0.000 claims description 126
238000009396 hybridization Methods 0.000 claims description 91
101710163270 Nuclease Proteins 0.000 claims description 90
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 84
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 66
238000001514 detection method Methods 0.000 claims description 60
230000014509 gene expression Effects 0.000 claims description 35
239000003795 chemical substances by application Substances 0.000 claims description 33
230000003993 interaction Effects 0.000 claims description 26
239000002773 nucleotide Substances 0.000 claims description 18
125000003729 nucleotide group Chemical group 0.000 claims description 18
201000010099 disease Diseases 0.000 claims description 15
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
239000000463 material Substances 0.000 claims description 12
239000003814 drug Substances 0.000 claims description 9
238000000338 in vitro Methods 0.000 claims description 6
230000003321 amplification Effects 0.000 claims description 4
238000001727 in vivo Methods 0.000 claims description 4
238000003199 nucleic acid amplification method Methods 0.000 claims description 4
238000012408 PCR amplification Methods 0.000 claims 1
230000008672 reprogramming Effects 0.000 claims 1
230000001225 therapeutic effect Effects 0.000 claims 1
238000003556 assay Methods 0.000 abstract description 76
238000012360 testing method Methods 0.000 abstract description 68
239000000126 substance Substances 0.000 abstract description 45
238000003491 array Methods 0.000 abstract description 21
239000000203 mixture Substances 0.000 abstract description 19
238000007373 indentation Methods 0.000 abstract 1
125000005647 linker group Chemical group 0.000 description 143
108020004999 messenger RNA Proteins 0.000 description 82
108091060211 Expressed sequence tag Proteins 0.000 description 80
238000004458 analytical method Methods 0.000 description 62
108090000623 proteins and genes Proteins 0.000 description 58
230000000295 complement effect Effects 0.000 description 55
230000027455 binding Effects 0.000 description 54
238000009739 binding Methods 0.000 description 54
108020005187 Oligonucleotide Probes Proteins 0.000 description 44
239000002751 oligonucleotide probe Substances 0.000 description 44
108090000765 processed proteins & peptides Proteins 0.000 description 39
210000004027 cell Anatomy 0.000 description 38
108020004414 DNA Proteins 0.000 description 28
108091033319 polynucleotide Proteins 0.000 description 28
102000040430 polynucleotide Human genes 0.000 description 28
239000002157 polynucleotide Substances 0.000 description 26
230000000875 corresponding effect Effects 0.000 description 25
239000000758 substrate Substances 0.000 description 24
102000004190 Enzymes Human genes 0.000 description 23
108090000790 Enzymes Proteins 0.000 description 23
238000006243 chemical reaction Methods 0.000 description 23
150000001875 compounds Chemical class 0.000 description 23
239000000047 product Substances 0.000 description 23
102000004196 processed proteins & peptides Human genes 0.000 description 22
108091000080 Phosphotransferase Proteins 0.000 description 20
239000002299 complementary DNA Substances 0.000 description 20
102000020233 phosphotransferase Human genes 0.000 description 20
239000000872 buffer Substances 0.000 description 17
239000004033 plastic Substances 0.000 description 17
229920003023 plastic Polymers 0.000 description 17
102000004169 proteins and genes Human genes 0.000 description 17
238000011534 incubation Methods 0.000 description 16
108020003175 receptors Proteins 0.000 description 16
102000005962 receptors Human genes 0.000 description 16
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 15
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 15
239000002585 base Substances 0.000 description 14
239000003446 ligand Substances 0.000 description 14
238000007792 addition Methods 0.000 description 13
239000003550 marker Substances 0.000 description 12
108010001336 Horseradish Peroxidase Proteins 0.000 description 11
238000003776 cleavage reaction Methods 0.000 description 11
-1 rRNA Proteins 0.000 description 11
230000007017 scission Effects 0.000 description 11
230000035945 sensitivity Effects 0.000 description 11
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
102100034343 Integrase Human genes 0.000 description 10
108091005804 Peptidases Proteins 0.000 description 10
239000004365 Protease Substances 0.000 description 10
238000005516 engineering process Methods 0.000 description 10
239000000284 extract Substances 0.000 description 10
238000012216 screening Methods 0.000 description 10
238000005406 washing Methods 0.000 description 10
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 9
239000013615 primer Substances 0.000 description 9
238000011282 treatment Methods 0.000 description 9
102000035195 Peptidases Human genes 0.000 description 8
230000008901 benefit Effects 0.000 description 8
230000007423 decrease Effects 0.000 description 8
238000010790 dilution Methods 0.000 description 8
239000012895 dilution Substances 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
108091093037 Peptide nucleic acid Proteins 0.000 description 7
239000011521 glass Substances 0.000 description 7
238000002372 labelling Methods 0.000 description 7
230000001681 protective effect Effects 0.000 description 7
108090001090 Lectins Proteins 0.000 description 6
102000004856 Lectins Human genes 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
230000000692 anti-sense effect Effects 0.000 description 6
229960002685 biotin Drugs 0.000 description 6
239000011616 biotin Substances 0.000 description 6
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 6
239000002523 lectin Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
238000011002 quantification Methods 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
239000004793 Polystyrene Substances 0.000 description 5
102000014400 SH2 domains Human genes 0.000 description 5
108050003452 SH2 domains Proteins 0.000 description 5
108010090804 Streptavidin Proteins 0.000 description 5
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 5
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 5
150000001413 amino acids Chemical class 0.000 description 5
239000000427 antigen Substances 0.000 description 5
108091007433 antigens Proteins 0.000 description 5
102000036639 antigens Human genes 0.000 description 5
235000020958 biotin Nutrition 0.000 description 5
239000002738 chelating agent Substances 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
238000013461 design Methods 0.000 description 5
229940079593 drug Drugs 0.000 description 5
229940000406 drug candidate Drugs 0.000 description 5
238000003384 imaging method Methods 0.000 description 5
210000004185 liver Anatomy 0.000 description 5
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
239000002245 particle Substances 0.000 description 5
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 5
230000035790 physiological processes and functions Effects 0.000 description 5
229920002223 polystyrene Polymers 0.000 description 5
230000008569 process Effects 0.000 description 5
239000011541 reaction mixture Substances 0.000 description 5
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
230000004568 DNA-binding Effects 0.000 description 4
108700039887 Essential Genes Proteins 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
229940124639 Selective inhibitor Drugs 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
238000007876 drug discovery Methods 0.000 description 4
239000012530 fluid Substances 0.000 description 4
238000013507 mapping Methods 0.000 description 4
238000004949 mass spectrometry Methods 0.000 description 4
238000005259 measurement Methods 0.000 description 4
229910052751 metal Inorganic materials 0.000 description 4
239000002184 metal Substances 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
229920001296 polysiloxane Polymers 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
102000053602 DNA Human genes 0.000 description 3
101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 3
101710151803 Mitochondrial intermediate peptidase 2 Proteins 0.000 description 3
101000819572 Mus musculus Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
108091028043 Nucleic acid sequence Proteins 0.000 description 3
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 3
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 3
239000013614 RNA sample Substances 0.000 description 3
108010083644 Ribonucleases Proteins 0.000 description 3
102000006382 Ribonucleases Human genes 0.000 description 3
102100023132 Transcription factor Jun Human genes 0.000 description 3
108020000999 Viral RNA Proteins 0.000 description 3
241000700605 Viruses Species 0.000 description 3
239000000556 agonist Substances 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
239000011230 binding agent Substances 0.000 description 3
238000007385 chemical modification Methods 0.000 description 3
230000002860 competitive effect Effects 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000002073 fluorescence micrograph Methods 0.000 description 3
238000000799 fluorescence microscopy Methods 0.000 description 3
238000013467 fragmentation Methods 0.000 description 3
238000006062 fragmentation reaction Methods 0.000 description 3
239000004009 herbicide Substances 0.000 description 3
230000002452 interceptive effect Effects 0.000 description 3
150000002500 ions Chemical group 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000004020 luminiscence type Methods 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000035772 mutation Effects 0.000 description 3
239000013642 negative control Substances 0.000 description 3
229910052759 nickel Inorganic materials 0.000 description 3
244000052769 pathogen Species 0.000 description 3
238000003909 pattern recognition Methods 0.000 description 3
239000000575 pesticide Substances 0.000 description 3
230000026731 phosphorylation Effects 0.000 description 3
238000006366 phosphorylation reaction Methods 0.000 description 3
239000013641 positive control Substances 0.000 description 3
238000000159 protein binding assay Methods 0.000 description 3
238000000926 separation method Methods 0.000 description 3
150000003384 small molecules Chemical class 0.000 description 3
239000000243 solution Substances 0.000 description 3
230000009870 specific binding Effects 0.000 description 3
238000001228 spectrum Methods 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
230000002103 transcriptional effect Effects 0.000 description 3
238000012546 transfer Methods 0.000 description 3
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
108091033380 Coding strand Proteins 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
238000004252 FT/ICR mass spectrometry Methods 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
229930010555 Inosine Natural products 0.000 description 2
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
108010086093 Mung Bean Nuclease Proteins 0.000 description 2
108020004711 Nucleic Acid Probes Proteins 0.000 description 2
108010038807 Oligopeptides Proteins 0.000 description 2
102000015636 Oligopeptides Human genes 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010001441 Phosphopeptides Proteins 0.000 description 2
241001136629 Pixus Species 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
102000001253 Protein Kinase Human genes 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
108020004682 Single-Stranded DNA Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
108020005202 Viral DNA Proteins 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
230000023555 blood coagulation Effects 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000011575 calcium Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000007541 cellular toxicity Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
238000010511 deprotection reaction Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
239000013024 dilution buffer Substances 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
230000005284 excitation Effects 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000002875 fluorescence polarization Methods 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
229910010272 inorganic material Inorganic materials 0.000 description 2
239000011147 inorganic material Substances 0.000 description 2
229960003786 inosine Drugs 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
150000002739 metals Chemical class 0.000 description 2
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 2
238000003032 molecular docking Methods 0.000 description 2
238000007899 nucleic acid hybridization Methods 0.000 description 2
239000002853 nucleic acid probe Substances 0.000 description 2
239000011368 organic material Substances 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
230000004962 physiological condition Effects 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920002704 polyhistidine Polymers 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
108060006633 protein kinase Proteins 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 2
NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
208000010370 Adenoviridae Infections Diseases 0.000 description 1
206010060931 Adenovirus infection Diseases 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
244000105975 Antidesma platyphyllum Species 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
235000017060 Arachis glabrata Nutrition 0.000 description 1
244000105624 Arachis hypogaea Species 0.000 description 1
235000010777 Arachis hypogaea Nutrition 0.000 description 1
235000018262 Arachis monticola Nutrition 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
230000028937 DNA protection Effects 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
108700020911 DNA-Binding Proteins Proteins 0.000 description 1
241000276484 Gadus ogac Species 0.000 description 1
102000002812 Heat-Shock Proteins Human genes 0.000 description 1
108010004889 Heat-Shock Proteins Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 description 1
101710203526 Integrase Proteins 0.000 description 1
241000239218 Limulus Species 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
101100268066 Mus musculus Zap70 gene Proteins 0.000 description 1
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
102000001490 Opioid Peptides Human genes 0.000 description 1
108010093625 Opioid Peptides Proteins 0.000 description 1
238000002944 PCR assay Methods 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
241000219833 Phaseolus Species 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
108010046983 Ribonuclease T1 Proteins 0.000 description 1
101150001535 SRC gene Proteins 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
102000004243 Tubulin Human genes 0.000 description 1
108090000704 Tubulin Proteins 0.000 description 1
102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
240000004922 Vigna radiata Species 0.000 description 1
235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
CESGKXMBHGUQTB-VONOSFMSSA-N [(1S,2S,6R,10S,11R,13S,14R,15R)-1,6,14-trihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(OC(=O)CCCCCCCCCCCCC)C(C)(C)[C@H]3[C@@H]21 CESGKXMBHGUQTB-VONOSFMSSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000000862 absorption spectrum Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
208000011589 adenoviridae infectious disease Diseases 0.000 description 1
238000005377 adsorption chromatography Methods 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
239000000910 agglutinin Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
239000003513 alkali Substances 0.000 description 1
238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
239000002269 analeptic agent Substances 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
238000003782 apoptosis assay Methods 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
238000000149 argon plasma sintering Methods 0.000 description 1
238000011948 assay development Methods 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
238000010256 biochemical assay Methods 0.000 description 1
238000005842 biochemical reaction Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000030833 cell death Effects 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
238000002144 chemical decomposition reaction Methods 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
238000002038 chemiluminescence detection Methods 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
238000004590 computer program Methods 0.000 description 1
238000001218 confocal laser scanning microscopy Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000003795 desorption Methods 0.000 description 1
230000023077 detection of light stimulus Effects 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000002408 directed self-assembly Methods 0.000 description 1
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
UKWLRLAKGMZXJC-QIECWBMSSA-L disodium;[4-chloro-3-[(3r,5s)-1-chloro-3'-methoxyspiro[adamantane-4,4'-dioxetane]-3'-yl]phenyl] phosphate Chemical compound [Na+].[Na+].O1OC2([C@@H]3CC4C[C@H]2CC(Cl)(C4)C3)C1(OC)C1=CC(OP([O-])([O-])=O)=CC=C1Cl UKWLRLAKGMZXJC-QIECWBMSSA-L 0.000 description 1
239000012636 effector Substances 0.000 description 1
238000010291 electrical method Methods 0.000 description 1
238000005401 electroluminescence Methods 0.000 description 1
239000012149 elution buffer Substances 0.000 description 1
230000013020 embryo development Effects 0.000 description 1
238000000295 emission spectrum Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
238000005530 etching Methods 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
238000000695 excitation spectrum Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
230000007614 genetic variation Effects 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
108091005608 glycosylated proteins Proteins 0.000 description 1
102000035122 glycosylated proteins Human genes 0.000 description 1
230000012010 growth Effects 0.000 description 1
235000009424 haa Nutrition 0.000 description 1
238000012203 high throughput assay Methods 0.000 description 1
238000012188 high-throughput screening assay Methods 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
239000005457 ice water Substances 0.000 description 1
238000012606 in vitro cell culture Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
206010022498 insulinoma Diseases 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
238000005304 joining Methods 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
230000004807 localization Effects 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
230000005499 meniscus Effects 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
238000005459 micromachining Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000004001 molecular interaction Effects 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
235000019799 monosodium phosphate Nutrition 0.000 description 1
230000009826 neoplastic cell growth Effects 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
230000006959 non-competitive inhibition Effects 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000010606 normalization Methods 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
238000002966 oligonucleotide array Methods 0.000 description 1
150000002482 oligosaccharides Polymers 0.000 description 1
239000003399 opiate peptide Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
208000021255 pancreatic insulinoma Diseases 0.000 description 1
239000000123 paper Substances 0.000 description 1
238000005192 partition Methods 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
238000000059 patterning Methods 0.000 description 1
235000020232 peanut Nutrition 0.000 description 1
238000011170 pharmaceutical development Methods 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
229940067631 phospholipid Drugs 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 1
108091005981 phosphorylated proteins Proteins 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
230000034918 positive regulation of cell growth Effects 0.000 description 1
229940124606 potential therapeutic agent Drugs 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
230000005522 programmed cell death Effects 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
150000003222 pyridines Chemical class 0.000 description 1
WVIICGIFSIBFOG-UHFFFAOYSA-N pyrylium Chemical class C1=CC=[O+]C=C1 WVIICGIFSIBFOG-UHFFFAOYSA-N 0.000 description 1
239000010453 quartz Substances 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000001525 receptor binding assay Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000011514 reflex Effects 0.000 description 1
102000037983 regulatory factors Human genes 0.000 description 1
108091008025 regulatory factors Proteins 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
238000009738 saturating Methods 0.000 description 1
238000004621 scanning probe microscopy Methods 0.000 description 1
238000002821 scintillation proximity assay Methods 0.000 description 1
238000012106 screening analysis Methods 0.000 description 1
229910052814 silicon oxide Inorganic materials 0.000 description 1
239000002210 silicon-based material Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
235000011008 sodium phosphates Nutrition 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000010959 steel Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
125000005207 tetraalkylammonium group Chemical group 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000008733 trauma Effects 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
230000004614 tumor growth Effects 0.000 description 1
239000000717 tumor promoter Substances 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
239000002435 venom Substances 0.000 description 1
231100000611 venom Toxicity 0.000 description 1
210000001048 venom Anatomy 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000001262 western blot Methods 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
- B01J2219/00662—Two-dimensional arrays within two-dimensional arrays
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Fats And Perfumes (AREA)
Signal Processing For Digital Recording And Reproducing (AREA)
Automatic Analysis And Handling Materials Therefor (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

NO20003115A 1997-12-19 2000-06-16 Fremgangsmate for pavisning av minst ett nukleinsyremal og sett for pavisning av minst ett nukleinsyremal i en prove NO329977B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US6829197P	1997-12-19	1997-12-19
US09/109,076 US6232066B1 (en)	1997-12-19	1998-07-02	High throughput assay system
PCT/US1998/027191 WO1999032663A2 (fr)	1997-12-19	1998-12-21	Systeme de dosage a haut rendement

Publications (3)

Publication Number	Publication Date
NO20003115D0 NO20003115D0 (no)	2000-06-16
NO20003115L NO20003115L (no)	2000-08-21
NO329977B1 true NO329977B1 (no)	2011-01-31

Family

ID=26748811

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20003115A NO329977B1 (no)	1997-12-19	2000-06-16	Fremgangsmate for pavisning av minst ett nukleinsyremal og sett for pavisning av minst ett nukleinsyremal i en prove

Country Status (19)

Country	Link
US (1)	US6232066B1 (fr)
EP (1)	EP1038033B1 (fr)
JP (5)	JP2001526904A (fr)
KR (1)	KR100708782B1 (fr)
CN (1)	CN1292076C (fr)
AT (1)	ATE392485T1 (fr)
AU (2)	AU1936699A (fr)
CA (1)	CA2315776C (fr)
CZ (1)	CZ302381B6 (fr)
DE (1)	DE69839373T2 (fr)
DK (1)	DK1038033T3 (fr)
EA (1)	EA006425B1 (fr)
ES (1)	ES2306484T3 (fr)
IL (2)	IL136862A0 (fr)
MX (1)	MXPA00006058A (fr)
NO (1)	NO329977B1 (fr)
NZ (1)	NZ505319A (fr)
PL (1)	PL193762B1 (fr)
WO (1)	WO1999032663A2 (fr)

Families Citing this family (214)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6720149B1 (en) *	1995-06-07	2004-04-13	Affymetrix, Inc.	Methods for concurrently processing multiple biological chip assays
CA2255599C (fr)	1996-04-25	2006-09-05	Bioarray Solutions, Llc	Assemblage electrocinetique de particules proches des surfaces regule par la lumiere
US7041510B2 (en) *	1996-04-25	2006-05-09	Bioarray Solutions Ltd.	System and method for programmable illumination pattern generation
CA2276462C (fr) *	1996-12-31	2007-06-12	Genometrix Incorporated	Procede et dispositif d'analyse moleculaire multiplexee
US20030096232A1 (en) *	1997-12-19	2003-05-22	Kris Richard M.	High throughput assay system
US6232066B1 (en)	1997-12-19	2001-05-15	Neogen, Inc.	High throughput assay system
US20100105572A1 (en) *	1997-12-19	2010-04-29	Kris Richard M	High throughput assay system
US20030039967A1 (en) *	1997-12-19	2003-02-27	Kris Richard M.	High throughput assay system using mass spectrometry
US6238869B1 (en) *	1997-12-19	2001-05-29	High Throughput Genomics, Inc.	High throughput assay system
DE69938623T2 (de)	1998-02-04	2009-05-28	Invitrogen Corp., Carlsbad	Microarrays und ihre verwendungen
CA2335951C (fr)	1998-06-24	2013-07-30	Mark S. Chee	Decodage de detecteurs matriciels a microspheres
US6406921B1 (en) *	1998-07-14	2002-06-18	Zyomyx, Incorporated	Protein arrays for high-throughput screening
US6576478B1 (en) *	1998-07-14	2003-06-10	Zyomyx, Inc.	Microdevices for high-throughput screening of biomolecules
US6780582B1 (en) *	1998-07-14	2004-08-24	Zyomyx, Inc.	Arrays of protein-capture agents and methods of use thereof
US20030138973A1 (en) *	1998-07-14	2003-07-24	Peter Wagner	Microdevices for screening biomolecules
US20020119579A1 (en) *	1998-07-14	2002-08-29	Peter Wagner	Arrays devices and methods of use thereof
US6908770B1 (en) *	1998-07-16	2005-06-21	Board Of Regents, The University Of Texas System	Fluid based analysis of multiple analytes by a sensor array
US6468476B1 (en) *	1998-10-27	2002-10-22	Rosetta Inpharmatics, Inc.	Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
US6950752B1 (en) *	1998-10-27	2005-09-27	Rosetta Inpharmatics Llc	Methods for removing artifact from biological profiles
AU2375600A (en) *	1998-12-22	2000-07-12	Stephen Felder	High throughput assay system using mass spectrometry
US7510841B2 (en) *	1998-12-28	2009-03-31	Illumina, Inc.	Methods of making and using composite arrays for the detection of a plurality of target analytes
EP1183387A2 (fr) *	1999-04-09	2002-03-06	Arcturus Engineering, Inc.	Reseau generique d'adnc ou de proteines destine a des bioanalyses personnalisees
US6221653B1 (en) *	1999-04-27	2001-04-24	Agilent Technologies, Inc.	Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids
US6395483B1 (en)	1999-09-02	2002-05-28	3M Innovative Properties Company	Arrays with mask layers
US6358557B1 (en) *	1999-09-10	2002-03-19	Sts Biopolymers, Inc.	Graft polymerization of substrate surfaces
US7244559B2 (en) *	1999-09-16	2007-07-17	454 Life Sciences Corporation	Method of sequencing a nucleic acid
EP1226571A4 (fr)	1999-09-17	2003-01-29	Bioarray Solutions Llc	Systeme et procede de generation programmable de motifs d'eclairage
US20030036070A1 (en) *	1999-10-21	2003-02-20	Shukti Chakravarti	Gene expression profiling of inflammatory bowel disease
US6656432B1 (en) *	1999-10-22	2003-12-02	Ngk Insulators, Ltd.	Micropipette and dividedly injectable apparatus
US6428957B1 (en)	1999-11-08	2002-08-06	Agilent Technologies, Inc.	Systems tools and methods of assaying biological materials using spatially-addressable arrays
JP4873812B2 (ja) *	1999-11-15	2012-02-08	キアジェンゲイサーズバーグインコーポレイテッド	マイクロアレイ上のｒｎａ：ｄｎａハイブリッドの免疫検出
MXPA02006095A (es) *	1999-12-21	2002-12-13	Johnson & Johnson	Deteccion de acidos nucleicos.
WO2001055454A1 (fr) *	2000-01-28	2001-08-02	Althea Technologies, Inc.	Procedes d'analyse de l'expression genique
US6770441B2 (en) *	2000-02-10	2004-08-03	Illumina, Inc.	Array compositions and methods of making same
US20020039728A1 (en) *	2000-02-10	2002-04-04	Robert Kain	Alternative substrates and formats for bead-based array of arrays
WO2001068673A1 (fr)	2000-03-14	2001-09-20	Active Motif	Analogues d'oligonucleotides, procedes de synthese et procedes de mise en oeuvre
US6962906B2 (en)	2000-03-14	2005-11-08	Active Motif	Oligonucleotide analogues, methods of synthesis and methods of use
US20040014644A1 (en) *	2000-03-14	2004-01-22	Vladimir Efimov	Oligonucleotide analogues and methods of use for modulating gene expression
CA2302827A1 (fr) *	2000-04-12	2001-10-12	Michelle Furtado	Denaturation de l'hybridation d'oligonucleotides et d'adn sur des surfaces
WO2003036265A2 (fr) *	2001-10-26	2003-05-01	Virtual Arrays, Inc.	Systemes de dosage a communication de fluides reglable
US7338773B2 (en) *	2000-04-14	2008-03-04	Millipore Corporation	Multiplexed assays of cell migration
US20020028455A1 (en) *	2000-05-03	2002-03-07	Laibinis Paul E.	Methods and reagents for assembling molecules on solid supports
TWI220927B (en) *	2000-05-12	2004-09-11	Rong-Seng Chang	Method for producing a micro-carrier
US9709559B2 (en)	2000-06-21	2017-07-18	Bioarray Solutions, Ltd.	Multianalyte molecular analysis using application-specific random particle arrays
AU7299301A (en)	2000-06-21	2002-01-02	Bioarray Solutions Ltd	Multianalyte molecular analysis using application-specific random particle arrays
CN1137999C (zh) *	2000-07-04	2004-02-11	清华大学	集成式微阵列装置
US6913879B1 (en)	2000-07-10	2005-07-05	Telechem International Inc.	Microarray method of genotyping multiple samples at multiple LOCI
EP1301632A2 (fr) *	2000-07-19	2003-04-16	Pointilliste, Inc.	Tri a plusieurs niveaux et le criblage a grande capacite
US7678539B2 (en) *	2000-08-10	2010-03-16	Corning Incorporated	Arrays of biological membranes and methods and use thereof
AU2001284867A1 (en) *	2000-08-14	2002-02-25	Surface Logix, Inc.	Biomolecule arrays
AU2001285219A1 (en) *	2000-08-24	2002-03-04	Aviva Biosciences Corporation	Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
US6900013B1 (en) *	2000-08-25	2005-05-31	Aviva Biosciences Corporation	Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
US20040185464A1 (en) *	2000-09-15	2004-09-23	Kris Richard M.	High throughput assay system
US20020081589A1 (en) *	2000-10-12	2002-06-27	Jing-Shan Hu	Gene expression monitoring using universal arrays
US20030152927A1 (en) *	2000-10-25	2003-08-14	Jakobsen Mogens Havsteen	Closed substrate platforms suitable for analysis of biomolecules
WO2002084302A2 (fr)	2000-11-08	2002-10-24	Burstein Technologies, Inc.	Systeme interactif pour l'analyse d'echantillons biologiques et le traitement de l'information y relative et son utilisation
US7351575B2 (en) *	2000-11-08	2008-04-01	Surface Logix, Inc.	Methods for processing biological materials using peelable and resealable devices
AU2002230419A1 (en) *	2000-11-08	2002-05-21	Science And Technology Corporation @Unm	Fluorescence and fret based assays for biomolecules on beads
US6699665B1 (en) *	2000-11-08	2004-03-02	Surface Logix, Inc.	Multiple array system for integrating bioarrays
US6905881B2 (en)	2000-11-30	2005-06-14	Paul Sammak	Microbead-based test plates and test methods for fluorescence imaging systems
EP1410026A2 (fr)	2000-12-08	2004-04-21	Burstein Technologies, Inc.	Techniques de detection d'analytes au moyen de disques optiques et de lecteurs de disques optiques
US7054258B2 (en)	2000-12-08	2006-05-30	Nagaoka & Co., Ltd.	Optical disc assemblies for performing assays
US6760298B2 (en)	2000-12-08	2004-07-06	Nagaoka & Co., Ltd.	Multiple data layer optical discs for detecting analytes
WO2002046721A2 (fr)	2000-12-08	2002-06-13	Burstein Technologies, Inc.	Disques optiques permettant de mesurer des analytes
US7776571B2 (en) *	2000-12-12	2010-08-17	Autogenomics, Inc.	Multi-substrate biochip unit
US6869766B2 (en) *	2000-12-22	2005-03-22	The Regents Of The University Of California	Gene associated with regulation of adiposity and insulin response
AU2002231189A1 (en) *	2000-12-22	2002-07-08	Burstein Technologies, Inc.	Optical bio-discs and methods relating thereto
US20090137416A1 (en)	2001-01-16	2009-05-28	Regeneron Pharmaceuticals, Inc.	Isolating Cells Expressing Secreted Proteins
US6949638B2 (en) *	2001-01-29	2005-09-27	Affymetrix, Inc.	Photolithographic method and system for efficient mask usage in manufacturing DNA arrays
AU2002255515A1 (en) *	2001-02-05	2002-08-19	Board Of Regents, The University Of Texas System	The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors
JP2002251091A (ja) *	2001-02-27	2002-09-06	Konica Corp	画像定着装置および画像形成装置
US20020146745A1 (en) *	2001-04-03	2002-10-10	Surromed, Inc.	Methods and reagents for multiplexed analyte capture, surface array self-assembly, and analysis of complex biological samples
US20030170623A1 (en) *	2001-04-13	2003-09-11	Jingwen Chen	Multiplexed gene analysis on a mobile solid support
US7572642B2 (en) *	2001-04-18	2009-08-11	Ambrigen, Llc	Assay based on particles, which specifically bind with targets in spatially distributed characteristic patterns
KR20020089746A (ko) *	2001-05-24	2002-11-30	주식회사 커벡스	크기변형유도 앵커 시발체, 이를 이용한 알티-피씨알 방법및 이를 이용한 진단 방법
US20030096264A1 (en) *	2001-06-18	2003-05-22	Psychiatric Genomics, Inc.	Multi-parameter high throughput screening assays (MPHTS)
US20060234231A1 (en) *	2001-06-20	2006-10-19	Nuevolution A/S	Microarrays displaying encoded molecules
EP1401850A1 (fr) *	2001-06-20	2004-03-31	Nuevolution A/S	Derives nucleosidiques pour elaboration de bibliotheque combinatoire
US7262063B2 (en)	2001-06-21	2007-08-28	Bio Array Solutions, Ltd.	Directed assembly of functional heterostructures
WO2003004993A2 (fr) *	2001-07-06	2003-01-16	Millipore Corporation	Membrane composite a motifs et son procede de fabrication au pochoir
US7141416B2 (en)	2001-07-12	2006-11-28	Burstein Technologies, Inc.	Multi-purpose optical analysis optical bio-disc for conducting assays and various reporting agents for use therewith
AU2002367825A1 (en) *	2001-07-30	2003-10-13	Sts Biopolymers, Inc.	Graft polymer matrices
US20050048566A1 (en) *	2001-08-27	2005-03-03	Delisi Charles	Apparatus, composition and method for proteome profiling
US20030044320A1 (en) *	2001-08-31	2003-03-06	Shun Luo	High throughput screening micro array platform
GB0124338D0 (en) *	2001-10-10	2001-11-28	Randox Lab Ltd	Biochips
ES2712173T3 (es)	2001-10-15	2019-05-09	Bioarray Solutions Ltd	Análisis multiplexado de loci polimórficos mediante consulta simultánea y detección mediada por enzimas
US20080187949A1 (en) *	2001-10-26	2008-08-07	Millipore Corporation	Multiplexed assays of cell migration
US7381375B2 (en) *	2001-10-26	2008-06-03	Millipore Corporation	Assay systems with adjustable fluid communication
ATE509272T1 (de)	2001-11-09	2011-05-15	3Dbiosurfaces Technologies Llc	Substrate mit hochliegendem oberflächenbereich für mikroarrays sowie verfahren zur herstellung davon
AU2002362013B2 (en) *	2001-11-21	2008-04-24	Applied Biosystems, Llc.	Digital assay
KR20030049802A (ko) *	2001-12-17	2003-06-25	권윤정	바이오 칩에서 프로브와 시료 핵산의 혼성화 여부를 효소반응으로 구별하는 방법
US20070178477A1 (en) *	2002-01-16	2007-08-02	Nanomix, Inc.	Nanotube sensor devices for DNA detection
US20060228723A1 (en) *	2002-01-16	2006-10-12	Keith Bradley	System and method for electronic sensing of biomolecules
US6989235B2 (en) *	2002-02-13	2006-01-24	Motorola, Inc.	Single molecule detection of bio-agents using the F1-ATPase biomolecular motor
CA2518626A1 (fr)	2002-03-15	2003-09-25	Nuevolution A/S	Procede ameliore pour la synthese de molecules matricees
WO2003090605A2 (fr) *	2002-04-26	2003-11-06	Board Of Regents, The University Of Texas System	Methode et systeme permettant de detecter des facteurs de risque cardiaque
WO2004061074A2 (fr) *	2002-05-14	2004-07-22	The Board Of Trustees Of The Leland Stanford Junior University	Genes endometriaux pour la detection de troubles endometriaux
US6841379B2 (en)	2002-05-15	2005-01-11	Beckman Coulter, Inc.	Conductive microplate
CA2487093A1 (fr) *	2002-05-24	2003-12-04	Nimblegen Systems, Inc.	Jeux ordonnes de microechantillons et procede permettant de declencher une reaction d'hybridation pour plusieurs echantillons sur un seul jeu ordonne
US20030232384A1 (en) *	2002-06-13	2003-12-18	Eastman Kodak Company	Microarray system utilizing microtiter plates
US7108976B2 (en) *	2002-06-17	2006-09-19	Affymetrix, Inc.	Complexity management of genomic DNA by locus specific amplification
US9388459B2 (en) *	2002-06-17	2016-07-12	Affymetrix, Inc.	Methods for genotyping
JP2005533256A (ja) *	2002-07-17	2005-11-04	ユー．エス．ジェノミクス，インコーポレイテッド	キメラタグを用いるポリマーを分析するための方法と組成物
US10730906B2 (en) *	2002-08-01	2020-08-04	Nuevolutions A/S	Multi-step synthesis of templated molecules
CA2539890A1 (fr) *	2002-09-27	2004-04-08	Carlsberg A/S	Matrice polymere a codage spatial
US7459273B2 (en) *	2002-10-04	2008-12-02	Affymetrix, Inc.	Methods for genotyping selected polymorphism
US20080207465A1 (en) *	2002-10-28	2008-08-28	Millipore Corporation	Assay systems with adjustable fluid communication
CN1720331B (zh)	2002-10-30	2013-01-02	纽韦卢森公司	合成双功能复合物的方法
EP1566635B1 (fr) *	2002-11-14	2011-12-07	Vivalis	Puce a reseau de micropuits pour la detection de lymphocytes specifiques d'antigenes, methode de detection de lymphocytes specifiques d'antigenes et methode de clonage du gene recepteur de l'antigene de lymphocytes specifiques d'antigenes
US7526114B2 (en)	2002-11-15	2009-04-28	Bioarray Solutions Ltd.	Analysis, secure access to, and transmission of array images
AU2003293511A1 (en) *	2002-12-11	2004-06-30	Arizona Board Of Regents, Acting For And On Behalf Of, Arizona State University	Polarization-enhanced detector with gold nanorods for detecting nanoscale rotational motion and method therefor
EP1756277B1 (fr)	2002-12-19	2009-12-02	Nuevolution A/S	Procedes de synthese guidee a fonction et structure quasi-selectives
EP1597577A4 (fr) *	2003-02-10	2007-02-21	Pointilliste Inc	Reseaux a assemblage autonome et utilisation de ceux-ci
EP1597395A2 (fr)	2003-02-21	2005-11-23	Nuevolution A/S	Procede de production d'une banque de deuxieme generation
US20040185499A1 (en) *	2003-03-20	2004-09-23	Jolley Michael E.	Method of epitope scanning using fluorescence polarization
WO2004097371A2 (fr) *	2003-04-25	2004-11-11	Board Of Regents, The University Of Texas System	Systeme et procede de detection d'analytes
US20050009066A1 (en) *	2003-05-15	2005-01-13	Connolly Dennis M.	Methods for localizing target molecules in a flowing fluid sample
US7651850B2 (en) *	2003-05-16	2010-01-26	Board Of Regents, The University Of Texas System	Image and part recognition technology
US9317922B2 (en)	2003-05-16	2016-04-19	Board Of Regents The University Of Texas System	Image and part recognition technology
ES2920892T3 (es)	2003-06-12	2022-08-11	Accupath Diagnostic Laboratories Inc	Método para formar matrices de células
US20040265883A1 (en) *	2003-06-27	2004-12-30	Biocept, Inc.	mRNA expression analysis
US8114978B2 (en)	2003-08-05	2012-02-14	Affymetrix, Inc.	Methods for genotyping selected polymorphism
DE602004026077D1 (de) *	2003-09-10	2010-04-29	Althea Technologies Inc	Erstellung von expressionsprofilen unter verwendung von mikroarrays
DK1670939T3 (da)	2003-09-18	2010-03-01	Nuevolution As	Fremgangsmåde til opnåelse af strukturel information om et kodet molekyle og fremgangsmåde til udvælgelse af forbindelser
US7927796B2 (en)	2003-09-18	2011-04-19	Bioarray Solutions, Ltd.	Number coding for identification of subtypes of coded types of solid phase carriers
CN1882699A (zh)	2003-09-22	2006-12-20	佰尔瑞溶液有限公司	带有多个能共价结合生物分子的官能基团的表面固定化多电解质
DK1691196T3 (da) *	2003-09-25	2013-04-15	Vivalis	Chip med mikrobrøndsarray og fremgangsmåde til fremstilling heraf
EP1692298A4 (fr)	2003-10-28	2008-08-13	Bioarray Solutions Ltd	Optimisation de l'analyse de l'expression genique a l'aide de sondes de capture immobilisees
JP2007509629A (ja)	2003-10-29	2007-04-19	バイオアレイソリューションズリミテッド	二本鎖ｄｎａの切断による複合核酸分析
GB2443819B (en) *	2003-11-17	2009-09-02	Univ Auburn	Methods and compositions for inhibiting intracellular aggregate formation
WO2005059551A2 (fr) *	2003-12-11	2005-06-30	Board Of Regents, The University Of Texas System	Procede et systeme destines a analyser la salive au moyen d'un reseau de capteurs
US7419820B2 (en) *	2003-12-16	2008-09-02	Canon Kabushiki Kaisha	Transfer sheet for transferring biologically active substance to culture plate
US7977048B2 (en) *	2004-01-13	2011-07-12	Pathogenetix, Inc.	Detection and quantification of analytes in solution using polymers
WO2005078122A2 (fr) *	2004-02-17	2005-08-25	Nuevolution A/S	Methode d'elimination visant a un enrichissement par hybridation de mesappariements
US8105849B2 (en)	2004-02-27	2012-01-31	Board Of Regents, The University Of Texas System	Integration of fluids and reagents into self-contained cartridges containing sensor elements
US8101431B2 (en)	2004-02-27	2012-01-24	Board Of Regents, The University Of Texas System	Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
JP2007529758A (ja) *	2004-03-19	2007-10-25	ユー．エス．ジェノミクス，インコーポレイテッド	単一分子の検出のための組成物および方法
CA2572450A1 (fr) *	2004-05-28	2005-12-15	Ambion, Inc.	Procedes et compositions faisant intervenir des molecules de micro-arn
US7848889B2 (en)	2004-08-02	2010-12-07	Bioarray Solutions, Ltd.	Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
CN100352937C (zh) *	2004-08-06	2007-12-05	中国海洋大学	对藻类进行定性与定量分析的方法
WO2006024023A2 (fr) *	2004-08-24	2006-03-02	Nanomix, Inc.	Dispositifs de detection a nanotubes, destines a la detection de sequences d'adn
US20060078894A1 (en) *	2004-10-12	2006-04-13	Winkler Matthew M	Methods and compositions for analyzing nucleic acids
EP2281888B1 (fr)	2004-11-12	2015-01-07	Asuragen, Inc.	Procédés et compositions impliquant l'ARNmi et des molécules inhibitrices de l'ARNmi
US20060246576A1 (en)	2005-04-06	2006-11-02	Affymetrix, Inc.	Fluidic system and method for processing biological microarrays in personal instrumentation
US7452671B2 (en) *	2005-04-29	2008-11-18	Affymetrix, Inc.	Methods for genotyping with selective adaptor ligation
WO2006119439A2 (fr) *	2005-05-03	2006-11-09	Althea Technologies, Inc.	Compositions et procedes d'analyse d'acides nucleiques degrades
AU2006309284B2 (en)	2005-05-31	2012-08-02	Board Of Regents, The University Of Texas System	Methods and compositions related to determination and use of white blood cell counts
US8486629B2 (en)	2005-06-01	2013-07-16	Bioarray Solutions, Ltd.	Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
US20070081163A1 (en) *	2005-06-03	2007-04-12	Minhua Liang	Method and apparatus for scanned beam microarray assay
EP2508867A1 (fr) *	2005-06-24	2012-10-10	Board Of Regents, The University Of Texas System	Systemes et procedes faisant appel a des cartouches autonomes comprenant des systemes de detection et des systemes de distribution de fluides
WO2007056250A2 (fr) *	2005-11-04	2007-05-18	U.S. Genomics, Inc.	Analyse heterogene d'analytes en solution au moyen de polymeres
WO2007061981A2 (fr) *	2005-11-21	2007-05-31	Lumera Corporation	Detecteur a resonance de plasmon en surface avec mecanisme de balayage d’angle entraine par actionneur
LT2341140T (lt) *	2005-12-01	2017-11-10	Nuevolution A/S	Fermentiniai kodavimo būdai efektyviai didelių bibliotekų sintezei
US7463358B2 (en) *	2005-12-06	2008-12-09	Lumera Corporation	Highly stable surface plasmon resonance plates, microarrays, and methods
US11306351B2 (en)	2005-12-21	2022-04-19	Affymetrix, Inc.	Methods for genotyping
JPWO2007074747A1 (ja) *	2005-12-26	2009-06-04	株式会社クラレ	細胞培養用材料
US20090176208A1 (en) *	2006-01-04	2009-07-09	Simon Brodie	Methods for detecting, identifying and reporting the presence of animal pathological agents
US20080003667A1 (en) *	2006-05-19	2008-01-03	Affymetrix, Inc.	Consumable elements for use with fluid processing and detection systems
EP2636755A1 (fr) *	2006-05-26	2013-09-11	AltheaDx Incorporated	Analyse biochimique de cellules divisées
US9957157B2 (en) *	2006-09-19	2018-05-01	University of Houtson System	Fabrication of self assembling nano-structures
CA2663962A1 (fr) *	2006-09-19	2008-03-27	Asuragen, Inc.	Genes regules mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p et voies de signalisation utiles comme cibles dans une intervention therapeutique
US20080131878A1 (en) *	2006-12-05	2008-06-05	Asuragen, Inc.	Compositions and Methods for the Detection of Small RNA
EP2104735A2 (fr) *	2006-12-08	2009-09-30	Asuragen, INC.	Gènes et voies génétiques régulés par mir-21 utilisés en tant que cibles pour une intervention thérapeutique
AU2007333106A1 (en) *	2006-12-08	2008-06-19	Asuragen, Inc.	miR-20 regulated genes and pathways as targets for therapeutic intervention
CN101627121A (zh) *	2006-12-08	2010-01-13	奥斯瑞根公司	作为治疗干预的靶标的miRNA调控基因和路径
EP2104737B1 (fr) *	2006-12-08	2013-04-10	Asuragen, INC.	Fonctions et cibles de microarn let-7
CA2671270A1 (fr) *	2006-12-29	2008-07-17	Asuragen, Inc.	Genes et voies regules par mir-16 utiles comme cibles pour intervention therapeutique
US20090232893A1 (en) *	2007-05-22	2009-09-17	Bader Andreas G	miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20080293589A1 (en) *	2007-05-24	2008-11-27	Affymetrix, Inc.	Multiplex locus specific amplification
EP2167138A2 (fr) *	2007-06-08	2010-03-31	Asuragen, INC.	Gènes et chemins régulés par mir-34 en tant que cibles pour une intervention thérapeutique
WO2009009127A2 (fr) *	2007-07-12	2009-01-15	U.S. Genomics, Inc.	Procédé et système de transfert et/ou de concentration d'un échantillon
JP4148367B1 (ja)	2007-08-02	2008-09-10	富山県	細胞のスクリーニング方法
US20090060786A1 (en) *	2007-08-29	2009-03-05	Gibum Kim	Microfluidic apparatus for wide area microarrays
US8361714B2 (en) *	2007-09-14	2013-01-29	Asuragen, Inc.	Micrornas differentially expressed in cervical cancer and uses thereof
US9388457B2 (en)	2007-09-14	2016-07-12	Affymetrix, Inc.	Locus specific amplification using array probes
WO2009052386A1 (fr) *	2007-10-18	2009-04-23	Asuragen, Inc.	Micro arn exprimés différentiellement dans des maladies pulmonaires et leurs utilisations
US8071562B2 (en) *	2007-12-01	2011-12-06	Mirna Therapeutics, Inc.	MiR-124 regulated genes and pathways as targets for therapeutic intervention
US8004669B1 (en)	2007-12-18	2011-08-23	Plexera Llc	SPR apparatus with a high performance fluid delivery system
WO2009086156A2 (fr) *	2007-12-21	2009-07-09	Asuragen, Inc.	Gènes et voies régulés par mir-10 servant de cibles dans le cadre d'une intervention thérapeutique
EP2260110B1 (fr) *	2008-02-08	2014-11-12	Asuragen, INC.	Micro arn (mirna) exprimés différentiellement dans des noeuds lymphoïdes prélevés chez des patients atteints d'un cancer
US9074244B2 (en)	2008-03-11	2015-07-07	Affymetrix, Inc.	Array-based translocation and rearrangement assays
US20090253780A1 (en) *	2008-03-26	2009-10-08	Fumitaka Takeshita	COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
JP5749156B2 (ja) *	2008-04-05	2015-07-15	シングルセルテクノロジー, インコーポレイテッドSingle Cell Technology, Inc.	生理活性物質の生産のための単一細胞を選抜する方法
US20090258928A1 (en) *	2008-04-08	2009-10-15	Asuragen, Inc.	Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
EP2285960B1 (fr)	2008-05-08	2015-07-08	Asuragen, INC.	Compositions et procédés liés à la modulation de miarn-184 de néovascularisation ou d angiogenèse
EP2297349A1 (fr) *	2008-06-04	2011-03-23	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Marqueurs du lymphome diffus à grandes cellules b et utilisations associées
RU2532359C2 (ru) *	2008-11-07	2014-11-10	Ф.Хоффманн-Ля Рош Аг	Мелкозернистые наполнители для фотометрических реактивных пленок
WO2010056737A2 (fr) *	2008-11-11	2010-05-20	Mirna Therapeutics, Inc.	Procédés et compositions impliquant des miarn dans des cellules souches cancéreuses
JP5745752B2 (ja) *	2009-05-21	2015-07-08	オリンパス株式会社	細胞スクリーニング方法、その方法に用いる制御ソフトウェア、細胞スクリーニング装置、及び画像解析装置、並びに細胞スクリーニングシステム
AU2010315303B2 (en) *	2009-11-03	2015-08-06	Htg Molecular Diagnostics, Inc.	Quantitative Nuclease Protection Sequencing (qNPS)
US11225655B2 (en)	2010-04-16	2022-01-18	Nuevolution A/S	Bi-functional complexes and methods for making and using such complexes
WO2012151111A1 (fr)	2011-05-04	2012-11-08	Htg Molecular Diagnostics, Inc.	Perfectionnements apportés à un dosage quantitatif (qnpa) et à un séquençage (qnps) avec protection contre la nucléase
AU2011372509B2 (en)	2011-07-01	2017-02-09	Htg Molecular Diagnostics, Inc.	Methods of detecting gene fusions
US9644241B2 (en)	2011-09-13	2017-05-09	Interpace Diagnostics, Llc	Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
ES2736977T3 (es) *	2011-09-14	2020-01-09	Ngk Insulators Ltd	Método para detectar ácido nucleico diana
WO2013058739A1 (fr) *	2011-10-18	2013-04-25	Hewlett-Packard Development Company, L.P.	Dispositif de détection moléculaire
EP2864500B1 (fr)	2012-06-22	2018-08-22	HTG Molecular Diagnostics, Inc.	Malignité moléculaire dans des lésions mélanocytiques
CN104603290B (zh) *	2012-06-29	2019-02-01	Htg分子诊断有限公司	用于检测核苷酸变异的核酸酶保护方法
US11181448B2 (en)	2012-11-06	2021-11-23	Biodot, Inc.	Controlled printing of a cell sample for karyotyping
TWI864338B (zh)	2012-11-14	2024-12-01	美商再生元醫藥公司	重組細胞表面捕捉蛋白質
JP6625519B2 (ja) *	2013-03-15	2019-12-25	イナノベイト，インコーポレイテッド	アッセイシステムおよびカートリッジデバイス
US11198900B2 (en)	2014-12-06	2021-12-14	Children's Medical Center Corporation	Nucleic acid-based linkers for detecting and measuring interactions
WO2016196824A1 (fr)	2015-06-02	2016-12-08	Children's Medical Center Corporation	Complexes d'acide nucléique pour le criblage de composés à codes à barres
US12077807B2 (en) *	2015-06-27	2024-09-03	The Research Foundation For The State University Of New York	Compositions and methods for analyte detection using nanoswitches
JP6836586B2 (ja)	2015-09-29	2021-03-03	エイチティージーモレキュラーダイアグノスティクス，インコーポレイテッド	びまん性大細胞型ｂ細胞性リンパ腫（ｄｌｂｃｌ）を亜型決定するための方法
WO2017139409A1 (fr)	2016-02-09	2017-08-17	Children's Medical Center Corporation	Procédé de détection d'analytes via des complexes polymères
WO2017165647A1 (fr)	2016-03-23	2017-09-28	Children's Medical Center Corporation	Détection et quantification rapides et sensibles d'analytes dans des échantillons complexes à l'aide de procédés à base de polymères
ES2840003T3 (es) *	2016-09-30	2021-07-06	Guardant Health Inc	Métodos para análisis multi-resolución de ácidos nucleicos libres de células
WO2018217689A1 (fr)	2017-05-22	2018-11-29	The Charles Stark Draper Laboratory, Inc.	Adn polymérase indépendante d'une molécule gabarit modifiée
US20190009240A1 (en) *	2017-07-10	2019-01-10	The Charles Stark Draper Laboratory, Inc.	Apparatus Enabling High Density Information Storage in Molecular Chains
WO2019069372A1 (fr) *	2017-10-03	2019-04-11	株式会社ニコン	Procédé de mesure de cible de détection, support d'ancrage de sonde de capture, kit de détection et dispositif de fluide
WO2019100080A1 (fr)	2017-11-20	2019-05-23	Children's Medical Center Corporation	Dosages de nanocommutateur commandé par une force pour détection de molécule unique dans des liquides biologiques complexes
WO2019222650A1 (fr)	2018-05-17	2019-11-21	The Charles Stark Draper Laboratory, Inc.	Appareil permettant un stockage d'informations de haute densité dans des chaînes moléculaires
GB2599709A (en) *	2020-10-09	2022-04-13	Qbd Qs Ip Ltd	Analysis system and method

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4228237A (en)	1978-09-21	1980-10-14	Calbiochem-Behring Corp.	Methods for the detection and determination of ligands
FI63596C (fi)	1981-10-16	1983-07-11	Orion Yhtymae Oy	Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
US4994373A (en)	1983-01-27	1991-02-19	Enzo Biochem, Inc.	Method and structures employing chemically-labelled polynucleotide probes
US5288609A (en)	1984-04-27	1994-02-22	Enzo Diagnostics, Inc.	Capture sandwich hybridization method and composition
US4751177A (en)	1985-06-13	1988-06-14	Amgen	Methods and kits for performing nucleic acid hybridization assays
US4868105A (en)	1985-12-11	1989-09-19	Chiron Corporation	Solution phase nucleic acid sandwich assay
US4925785A (en)	1986-03-07	1990-05-15	Biotechnica Diagnostics, Inc.	Nucleic acid hybridization assays
US5374524A (en)	1988-05-10	1994-12-20	E. I. Du Pont De Nemours And Company	Solution sandwich hybridization, capture and detection of amplified nucleic acids
ATE173508T1 (de)	1988-05-20	1998-12-15	Hoffmann La Roche	Befestigung von sequenzspezifischen proben
US6040138A (en)	1995-09-15	2000-03-21	Affymetrix, Inc.	Expression monitoring by hybridization to high density oligonucleotide arrays
US5143854A (en)	1989-06-07	1992-09-01	Affymax Technologies N.V.	Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5547839A (en)	1989-06-07	1996-08-20	Affymax Technologies N.V.	Sequencing of surface immobilized polymers utilizing microflourescence detection
US5744101A (en)	1989-06-07	1998-04-28	Affymax Technologies N.V.	Photolabile nucleoside protecting groups
US5252743A (en)	1989-11-13	1993-10-12	Affymax Technologies N.V.	Spatially-addressable immobilization of anti-ligands on surfaces
JPH05502585A (ja) *	1989-12-04	1993-05-13	ベクトン　ディッキンソン　アンド　カンパニー	ポリマーに共有結合したオリゴヌクレオチドの利用により向上される標的核酸の捕獲
AU7762091A (en)	1990-03-30	1991-10-30	City Of Hope	Detection of minimal residual disease in lymphoid malignancies
US5556748A (en)	1991-07-30	1996-09-17	Xenopore Corporation	Methods of sandwich hybridization for the quantitative analysis of oligonucleotides
ES2092056T3 (es)	1991-09-23	1996-11-16	Pfizer	Procedimiento para detectar arnm y adn especificos en celulas.
US5324633A (en)	1991-11-22	1994-06-28	Affymax Technologies N.V.	Method and apparatus for measuring binding affinity
US5985583A (en) *	1992-06-23	1999-11-16	Mount Sinai School Of Medicine Of The City University Of New York	Cloning and expression of gonadotropin-releasing hormone receptor
US5605798A (en)	1993-01-07	1997-02-25	Sequenom, Inc.	DNA diagnostic based on mass spectrometry
ATE244406T1 (de)	1993-05-10	2003-07-15	Nissui Pharm Co Ltd	Verfahren zur bestimmung von mehr als einem immunologischen liganden und bestimmungsreagenz sowie satz dafuer
JPH079468A (ja) *	1993-06-24	1995-01-13	Sekisui Chem Co Ltd	熱可塑性樹脂成型体の製造方法
DE19518217A1 (de)	1994-05-11	1995-11-30	Imtec Immundiagnostika Gmbh	Verfahren und Vorrichtung zur qualitativen und quantitativen Bestimmung von Desoxyribonukleinsäure (DNA) auf festen Phasen
US5807522A (en) *	1994-06-17	1998-09-15	The Board Of Trustees Of The Leland Stanford Junior University	Methods for fabricating microarrays of biological samples
ZA956776B (en) *	1994-08-25	1996-03-20	Akzo Nobel Nv	A process for making the product of a nucleic acid amplification reaction incapable of being a target for further amplification a diagnostic assay employing said process a kit and a container suitable for carrying out said process for assay
US6974666B1 (en)	1994-10-21	2005-12-13	Appymetric, Inc.	Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
DE19516196A1 (de)	1995-05-08	1996-11-14	Boehringer Mannheim Gmbh	Verfahren zum quantitativen Nachweis von Nukleinsäuren
WO1996035778A1 (fr) *	1995-05-11	1996-11-14	Human Genome Sciences, Inc.	Uridine diphosphate galactose-4-epimerase humaine
US5545531A (en)	1995-06-07	1996-08-13	Affymax Technologies N.V.	Methods for making a device for concurrently processing multiple biological chip assays
FR2737502B1 (fr)	1995-07-31	1997-10-24	Genset Sa	Procede de detection d'acides nucleiques utilisant des sondes nucleotidiques permettant a la fois une capture specifique et une detection
WO1997007245A1 (fr)	1995-08-14	1997-02-27	Ely Michael Rabani	Procedes et dispositifs de sequençage multiplex parallele de polynucleotides
US5661028A (en)	1995-09-29	1997-08-26	Lockheed Martin Energy Systems, Inc.	Large scale DNA microsequencing device
AU2253397A (en)	1996-01-23	1997-08-20	Affymetrix, Inc.	Nucleic acid analysis techniques
DE819167T1 (de) *	1996-01-24	1998-04-09	Synaptic Pharma Corp	Dns codierend für galanin galr2 rezeptoren und deren verwendung
EP2574617B1 (fr)	1996-02-09	2016-04-20	Cornell Research Foundation, Inc.	Détection de différences entre séquences d'acide nucléique faisant appel à la réaction de détection de ligase et à des réseaux adressables
EP0886681A1 (fr)	1996-03-04	1998-12-30	Genetrace Systems, Inc.	Methodes de criblage des acides nucleiques par spectrometrie de masse
US5770370A (en)	1996-06-14	1998-06-23	David Sarnoff Research Center, Inc.	Nuclease protection assays
CA2276462C (fr)	1996-12-31	2007-06-12	Genometrix Incorporated	Procede et dispositif d'analyse moleculaire multiplexee
US6232066B1 (en)	1997-12-19	2001-05-15	Neogen, Inc.	High throughput assay system
KR100709468B1 (ko) *	2004-11-09	2007-04-18	주식회사 하이닉스반도체	플래시 메모리 소자의 플로팅 게이트 형성방법

1998
- 1998-07-02 US US09/109,076 patent/US6232066B1/en not_active Expired - Lifetime
- 1998-12-21 NZ NZ505319A patent/NZ505319A/xx unknown
- 1998-12-21 WO PCT/US1998/027191 patent/WO1999032663A2/fr not_active Ceased
- 1998-12-21 DK DK98964187T patent/DK1038033T3/da active
- 1998-12-21 CA CA2315776A patent/CA2315776C/fr not_active Expired - Lifetime
- 1998-12-21 AU AU19366/99A patent/AU1936699A/en not_active Abandoned
- 1998-12-21 DE DE69839373T patent/DE69839373T2/de not_active Expired - Lifetime
- 1998-12-21 KR KR1020007006774A patent/KR100708782B1/ko not_active Expired - Fee Related
- 1998-12-21 PL PL98342898A patent/PL193762B1/pl not_active IP Right Cessation
- 1998-12-21 CN CNB988132737A patent/CN1292076C/zh not_active Expired - Lifetime
- 1998-12-21 EP EP98964187A patent/EP1038033B1/fr not_active Expired - Lifetime
- 1998-12-21 AT AT98964187T patent/ATE392485T1/de active
- 1998-12-21 ES ES98964187T patent/ES2306484T3/es not_active Expired - Lifetime
- 1998-12-21 MX MXPA00006058A patent/MXPA00006058A/es not_active IP Right Cessation
- 1998-12-21 IL IL13686298A patent/IL136862A0/xx active IP Right Grant
- 1998-12-21 EA EA200000684A patent/EA006425B1/ru not_active IP Right Cessation
- 1998-12-21 CZ CZ20002259A patent/CZ302381B6/cs not_active IP Right Cessation
- 1998-12-21 JP JP2000525580A patent/JP2001526904A/ja active Pending
2000
- 2000-06-16 NO NO20003115A patent/NO329977B1/no not_active IP Right Cessation
- 2000-06-18 IL IL136862A patent/IL136862A/en not_active IP Right Cessation
2003
- 2003-08-12 AU AU2003234756A patent/AU2003234756A1/en not_active Abandoned
2009
- 2009-02-02 JP JP2009021456A patent/JP2009183286A/ja not_active Withdrawn
- 2009-10-09 JP JP2009234964A patent/JP2010046072A/ja active Pending
2011
- 2011-02-04 JP JP2011023036A patent/JP5049395B2/ja not_active Expired - Lifetime
2012
- 2012-02-03 JP JP2012022239A patent/JP2012090644A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
IL136862A0 (en)	2001-06-14
JP2010046072A (ja)	2010-03-04
KR100708782B1 (ko)	2007-04-18
ES2306484T3 (es)	2008-11-01
PL342898A1 (en)	2001-07-16
EA200000684A1 (ru)	2001-02-26
CZ20002259A3 (cs)	2001-07-11
EP1038033B1 (fr)	2008-04-16
US6232066B1 (en)	2001-05-15
WO1999032663A3 (fr)	2000-02-17
NO20003115L (no)	2000-08-21
CA2315776A1 (fr)	1999-07-01
IL136862A (en)	2006-07-05
CA2315776C (fr)	2011-11-29
PL193762B1 (pl)	2007-03-30
CZ302381B6 (cs)	2011-04-27
AU2003234756A1 (en)	2003-09-11
MXPA00006058A (es)	2004-09-10
JP5049395B2 (ja)	2012-10-17
DE69839373D1 (de)	2008-05-29
DK1038033T3 (da)	2008-08-18
WO1999032663A2 (fr)	1999-07-01
DE69839373T2 (de)	2009-06-04
NZ505319A (en)	2002-11-26
NO20003115D0 (no)	2000-06-16
AU1936699A (en)	1999-07-12
ATE392485T1 (de)	2008-05-15
JP2001526904A (ja)	2001-12-25
EP1038033A2 (fr)	2000-09-27
CN1292076C (zh)	2006-12-27
CN1290306A (zh)	2001-04-04
KR20010033324A (ko)	2001-04-25
JP2011135884A (ja)	2011-07-14
JP2012090644A (ja)	2012-05-17
JP2009183286A (ja)	2009-08-20
EA006425B1 (ru)	2005-12-29

Publication	Publication Date	Title
CA2315776C (fr)	2011-11-29	Systeme de dosage a haut rendement
US6458533B1 (en)	2002-10-01	High throughput assay system for monitoring ESTs
CA2377567C (fr)	2011-11-29	Systeme d'analyse extremement productif
CA2452819C (fr)	2012-11-27	Systeme de dosage a rendement eleve
WO2000037684A1 (fr)	2000-06-29	Systeme d'analyse a haut rendement mettant en oeuvre la spectrometrie de masse
US20100105572A1 (en)	2010-04-29	High throughput assay system
US20030039967A1 (en)	2003-02-27	High throughput assay system using mass spectrometry
US20040185464A1 (en)	2004-09-23	High throughput assay system
AU2007231625B2 (en)	2011-04-07	High Throughput Assay System
AU2006201464B2 (en)	2008-06-12	High Throughput Assay System

Legal Events

Date	Code	Title	Description
2012-07-23	MM1K	Lapsed by not paying the annual fees